subscribeSubscribe
price-trendAsk Us
IPC Secures Distribution Rights to Independent Retail Pharmacies for BRENZAVVY

IPC Secures Distribution Rights to Independent Retail Pharmacies for BRENZAVVY
PR NEWSWIRE
01 Feb 2024
Share Share
CV Safety Profile of TheracosBio’s BRENZAVVY Confirmed in Research Published

CV Safety Profile of TheracosBio’s BRENZAVVY Confirmed in Research Published
BUSINESSWIRE
08 Jan 2024
Share Share
TheracosBio, IPC Announce Partnership to Make BRENZAVVY Available

TheracosBio, IPC Announce Partnership to Make BRENZAVVY Available
BUSINESSWIRE
20 Dec 2023
Share Share
TheracosBio and SmithRx Collaborate to Offer Approved Diabetes Drug Brenzavvy

TheracosBio and SmithRx Collaborate to Offer Approved Diabetes Drug Brenzavvy
BUSINESSWIRE
17 Aug 2023
Share Share
TheracosBio Announces Publication of Data on the Safety of Brenzavvy

TheracosBio Announces Publication of Data on the Safety of Brenzavvy
BUSINESSWIRE
04 Aug 2023
Share Share
TheracosBio Announces Commercial Availability of Brenzavvy

TheracosBio Announces Commercial Availability of Brenzavvy
BUSINESSWIRE
13 Jul 2023
Share Share
Piramal Supports Theracosbio With Integrated Drug Substance Program For Bexagliflozin

Piramal Supports Theracosbio With Integrated Drug Substance Program For Bexagliflozin
PR NEWSWIRE
30 Mar 2023
Share Share
TheracosBio wins FDA green light for new diabetes med

TheracosBio wins FDA green light for new diabetes med
Fraiser Kansteiner FIERCE PHARMA
24 Jan 2023
Share Share
Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)

Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)
BUSINESSWIRE
09 Dec 2022
Share Share